CIBA Vision and CooperVision Inc. reported they have reached an agreement to settle patent litigation that resolves all current patent infringement lawsuits between the two companies. CIBA Vision, the Duluth, Ga.-based eye-care unit of Novartis, said it has licensed its so called "Nicolson" patents to CooperVision. This will enable both companies to move forward in bringing forth new and improved products. The Nicolson patents cover high-oxygen-transmissible contact lenses, including CIBA Vision's O2OPTIX AIR OPTIXand NIGHT & DAY silicone hydrogel contact lenses. In exchange, CooperVision will pay CIBA Vision a royalty on U.S. sales of its Biofinity contact lenses until 2014 and on sales outside of the United States until 2016. CIBA Vision also has licensed two types of patents from CooperVision related to contact lens designs.
No comments:
Post a Comment